Literature DB >> 15226877

Carnitine deficiency as the possible etiology of idiopathic mitral valve prolapse: case study with speculative annotation.

M Trivellato1, E De Palo, R Gatti, A Parenti, M Piazza.   

Abstract

UNLABELLED: Idiopathic mitral valve prolapse (IMVP) is a very common cardiac abnormality that may be linked to carnitine deficit (inadequate nutritional intake or absorption). One patient with IMVP and related symptoms that were resistant to drug therapy was fully studied. Free plasma carnitine and 24-hour free urine carnitine were measured twice, 10 days apart, after an overnight fast.
FINDINGS: Free plasma carnitine 23 and 28 microM/L (our laboratory N=38+/-2 microM/L); free urine C 25 and 44 microM/24 hr (N=255+/-66 microM/24 hr); FFA 0.88 mEq/L, Duncombe method (N=0.09-0.60); LDL 42% (N = 44-65); cholesterol 161 mg/dl (N = 180-280); triglycerides 84 mg/dl (N = 50-172); SGOT 79 MU/ml (N = up to 40); SGPT 147 MU/ml (N = up to 40); OCT 11.2 MU/ml (N = up to 10.0); aldolase 11.5 MU/ml (N = up to 3.1, Bruns method). Deltoid biopsy: light microscopy showed the presence of optically empty vacuoles; electron microscopy showed lipid droplets near the subsarcolemma area and intermyofibrillar spaces. The mitochondria contained electron dense granules. The electromyogram was also abnormal. In a random sample of four patients with IMVP and related classic symptoms, we have found low levels of plasma and/or urinary carnitine in each case. This study may be the first step towards L-carnitine therapy for what has previously appeared to be idiopathic cardiomyopathy.

Entities:  

Year:  1984        PMID: 15226877      PMCID: PMC351712     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  20 in total

1.  Mitral insufficiency due to myxomatous transformation: "Floppy valve syndrome".

Authors:  D A Cooley; S Gerami; G L Hallman; D C Wukasch; R J Hall
Journal:  J Cardiovasc Surg (Torino)       Date:  1972 Jul-Aug       Impact factor: 1.888

2.  Myocardial carnitine deficiency in chronic heart failure.

Authors:  Y Suzuki; Y Masumura; A Kobayashi; N Yamazaki; Y Harada; M Osawa
Journal:  Lancet       Date:  1982-01-09       Impact factor: 79.321

3.  Sudden death in primary mitral valve prolapse.

Authors:  W A Pocock; C K Bosman; E Chesler; J B Barlow; J E Edwards
Journal:  Am Heart J       Date:  1984-02       Impact factor: 4.749

4.  Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study.

Authors:  D D Savage; R J Garrison; R B Devereux; W P Castelli; S J Anderson; D Levy; P M McNamara; J Stokes; W B Kannel; M Feinleib
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

5.  Stimulation of oxidation of mitochondrial fatty acids and of acetate by acetylcarnitine.

Authors:  N Siliprandi; D Siliprandi; M Ciman
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

6.  [Lipidic myopathy with severe cardiomyopathy caused by a generalized carnitine deficiency. Favourable course during carnitine hydrochloride treatment].

Authors:  P Morand; F Despert; H N Carrier; B M Saudubray; M Fardeau; B Romieux; C Fauchier; P Combe
Journal:  Arch Mal Coeur Vaiss       Date:  1979-05

7.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

8.  [Myocardiopathy with lipid overload and leukocyte palmityl carnitine transferase (PCT) deficiency].

Authors:  A Sacrez; A Porte; C Hindelang; R Bieth; B Mérian
Journal:  Arch Mal Coeur Vaiss       Date:  1982-12

9.  Diastolic sounds and murmurs associated with mitral valve prolapse.

Authors:  J Y Wei; N J Fortuin
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

10.  Muscle carnitine deficiency and fatal cardiomyopathy.

Authors:  Z H Hart; C H Chang; S Di Mauro; Q Farooki; R Ayyar
Journal:  Neurology       Date:  1978-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.